Presentation - EN

The Liver Biobanks Network was established in the early 2000s in response to the rise of genomics and large-scale biology, which revolutionized biomedical research and created a pressing need for high-quality biological samples.

Leading centers specialized in the treatment of patients with liver tumors, along with their biobanks, came together to form a network collecting biological samples, including both tumor and non-tumor tissues from hepatocellular carcinomas, cholangiocarcinomas, as well as benign liver tumours. In addition, the Network collects other biological materials such as blood and its derivatives.

The Network also gathers the data associated with these samples -including epidemiological, clinical, biological, and histopathological annotations- whithin a central database managed by The French Institute for Medical Research (Inserm).

Its goal is to make these resources available to academic and industrial researchers, both in France and internationally, in order to promote collaborative research projects.

In 2002, the Network was officially recognized by Inserm, the Ministry of Research, the Ministry of Health, and the National Cancer Institute, in response to various calls for projects aimed at structuring infrastructures for managing human sample collections in France (IBiSA, ANR, INCa, PIA).

Partner Centers